{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:52:05Z","timestamp":1791395525241,"version":"4.3.3"},"reference-count":165,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"DOI":"10.1038\/s41574-026-01309-x","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:26:05Z","timestamp":1791386765000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glycation and receptors: coming of AGE in the midst of danger"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8902-070X","authenticated-orcid":false,"given":"Ann Marie","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2649-2675","authenticated-orcid":false,"given":"Alexander","family":"Shekhtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravichandran","family":"Ramasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"1309_CR1","first-page":"66","volume":"154","author":"LC Maillard","year":"1912","unstructured":"Maillard, L. C. Action of amino acids on sugars. Formation of melanoidins in a methodical way (in French). C. R. Acad. Sci. 154, 66\u201368 (1912).","journal-title":"C. R. Acad. Sci."},{"key":"1309_CR2","first-page":"169","volume":"10","author":"JE Hodge","year":"1955","unstructured":"Hodge, J. E. The Amadori rearrangement. Adv. Carbohydr. Chem. 10, 169\u2013205 (1955).","journal-title":"Adv. Carbohydr. Chem."},{"key":"1309_CR3","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/0009-8981(68)90372-0","volume":"22","author":"S Rahbar","year":"1968","unstructured":"Rahbar, S. An abnormal hemoglobin in red cells of diabetics. Clin. Chim. Acta 22, 296\u2013298 (1968).","journal-title":"Clin. Chim. Acta"},{"key":"1309_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/BF00814000","volume":"1","author":"F Hayase","year":"1991","unstructured":"Hayase, F. et al. Enzymatic metabolism of 3-deoxyglucosone, a Maillard intermediate. Amino Acids 1, 307\u2013318 (1991).","journal-title":"Amino Acids"},{"key":"1309_CR5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1432-1033.1991.tb15921.x","volume":"197","author":"ZQ Liang","year":"1991","unstructured":"Liang, Z. Q., Hayase, F. & Kato, H. Purification and characterization of NADPH-dependent 2-oxoaldehyde reductase from porcine liver. A self-defence enzyme preventing the advanced stage of the Maillard reaction. Eur. J. Biochem. 197, 373\u2013379 (1991).","journal-title":"Eur. J. Biochem."},{"key":"1309_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1196\/annals.1333.014","volume":"1043","author":"PJ Thornalley","year":"2005","unstructured":"Thornalley, P. J. Dicarbonyl intermediates in the Maillard reaction. Ann. N. Y. Acad. Sci. 1043, 111\u2013117 (2005).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"1309_CR7","doi-asserted-by":"publisher","first-page":"10017","DOI":"10.1074\/jbc.270.17.10017","volume":"270","author":"MA Glomb","year":"1995","unstructured":"Glomb, M. A. & Monnier, V. M. Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction. J. Biol. Chem. 270, 10017\u201310026 (1995).","journal-title":"J. Biol. Chem."},{"key":"1309_CR8","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/0003-9861(92)90146-N","volume":"294","author":"KJ Knecht","year":"1992","unstructured":"Knecht, K. J., Feather, M. S. & Baynes, J. W. Detection of 3-deoxyfructose and 3-deoxyglucosone in human urine and plasma: evidence for intermediate stages of the Maillard reaction in vivo. Arch. Biochem. Biophys. 294, 130\u2013137 (1992).","journal-title":"Arch. Biochem. Biophys."},{"key":"1309_CR9","doi-asserted-by":"publisher","first-page":"10872","DOI":"10.1021\/bi00034a021","volume":"34","author":"S Reddy","year":"1995","unstructured":"Reddy, S., Bichler, J., Wells-Knecht, K. J., Thorpe, S. R. & Baynes, J. W. N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry 34, 10872\u201310878 (1995).","journal-title":"Biochemistry"},{"key":"1309_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/BF01910730","volume":"30","author":"DG Dyer","year":"1991","unstructured":"Dyer, D. G. et al. The Maillard reaction in vivo. Z. Ernahrungswiss. 30, 29\u201345 (1991).","journal-title":"Z. Ernahrungswiss."},{"key":"1309_CR11","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.3390\/cells11081312","volume":"11","author":"A Twarda-Clapa","year":"2022","unstructured":"Twarda-Clapa, A., Olczak, A., Bia\u0142kowska, A. M. & Kozio\u0142kiewicz, M. Advanced glycation end-products (AGEs): formation, chemistry, classification, receptors, and diseases related to AGEs. Cells 11, 1312 (2022).","journal-title":"Cells"},{"key":"1309_CR12","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1172\/JCI115216","volume":"87","author":"TJ Lyons","year":"1991","unstructured":"Lyons, T. J., Bailie, K. E., Dyer, D. G., Dunn, J. A. & Baynes, J. W. Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus. J. Clin. Invest. 87, 1910\u20131915 (1991).","journal-title":"J. Clin. Invest."},{"key":"1309_CR13","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1056\/NEJM198805193182007","volume":"318","author":"M Brownlee","year":"1988","unstructured":"Brownlee, M., Cerami, A. & Vlassara, H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 318, 1315\u20131321 (1988).","journal-title":"N. Engl. J. Med."},{"key":"1309_CR14","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1073\/pnas.75.6.2918","volume":"75","author":"VJ Stevens","year":"1978","unstructured":"Stevens, V. J., Rouzer, C. A., Monnier, V. M. & Cerami, A. Diabetic cataract formation: potential role of glycosylation of lens crystallins. Proc. Natl Acad. Sci. USA 75, 2918\u20132922 (1978).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1309_CR15","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1126\/science.6779377","volume":"211","author":"VM Monnier","year":"1981","unstructured":"Monnier, V. M. & Cerami, A. Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. Science 211, 491\u2013493 (1981).","journal-title":"Science"},{"key":"1309_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.20463\/jenb.2017.0027","volume":"21","author":"CS Kim","year":"2017","unstructured":"Kim, C. S., Park, S. & Kim, J. The role of glycation in the pathogenesis of aging and its prevention through herbal products and physical exercise. J. Exerc. Nutr. Biochem. 21, 55\u201361 (2017).","journal-title":"J. Exerc. Nutr. Biochem."},{"key":"1309_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4196\/kjpp.2014.18.1.1","volume":"18","author":"VP Singh","year":"2014","unstructured":"Singh, V. P., Bali, A., Singh, N. & Jaggi, A. S. Advanced glycation end products and diabetic complications. Korean J. Physiol. Pharmacol. 18, 1\u201314 (2014).","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"1309_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2337\/diab.40.4.405","volume":"40","author":"JW Baynes","year":"1991","unstructured":"Baynes, J. W. Role of oxidative stress in development of complications in diabetes. Diabetes 40, 405\u2013412 (1991).","journal-title":"Diabetes"},{"key":"1309_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/ndt\/11.supp5.48","volume":"11","author":"JR Requena","year":"1996","unstructured":"Requena, J. R. et al. Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions. Nephrol. Dial. Transpl. 11, 48\u201353 (1996).","journal-title":"Nephrol. Dial. Transpl."},{"key":"1309_CR20","first-page":"23","volume":"13","author":"JH Yeung","year":"1991","unstructured":"Yeung, J. H. Effects of glycerol-induced acute renal failure on tissue glutathione and glutathione-dependent enzymes in the rat. Methods Find. Exp. Clin. Pharmacol. 13, 23\u201328 (1991).","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"1309_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3109\/10715762.2013.792926","volume":"47","author":"G Aldini","year":"2013","unstructured":"Aldini, G. et al. Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products. Free Radic. Res. 47, 93\u2013137 (2013).","journal-title":"Free Radic. Res."},{"key":"1309_CR22","first-page":"1352","volume":"74","author":"N Kawamura","year":"1992","unstructured":"Kawamura, N. et al. Increased glycated Cu,Zn-superoxide dismutase levels in erythrocytes of patients with insulin-dependent diabetis mellitus. J. Clin. Endocrinol. Metab. 74, 1352\u20131354 (1992).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1309_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1172\/JCI3042","volume":"104","author":"MM Anderson","year":"1999","unstructured":"Anderson, M. M., Requena, J. R., Crowley, J. R., Thorpe, S. R. & Heinecke, J. W. The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation. J. Clin. Invest. 104, 103\u2013113 (1999).","journal-title":"J. Clin. Invest."},{"key":"1309_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037917","volume":"7","author":"K Byun","year":"2012","unstructured":"Byun, K. et al. Induction of neuronal death by microglial AGE-albumin: implications for Alzheimer\u2019s disease. PLoS ONE 7, e37917 (2012).","journal-title":"PLoS ONE"},{"key":"1309_CR25","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.biochi.2010.12.003","volume":"93","author":"P Rondeau","year":"2011","unstructured":"Rondeau, P. & Bourdon, E. The glycation of albumin: structural and functional impacts. Biochimie 93, 645\u2013658 (2011).","journal-title":"Biochimie"},{"key":"1309_CR26","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","volume":"12","author":"P Matzinger","year":"1994","unstructured":"Matzinger, P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991\u20131045 (1994).","journal-title":"Annu. Rev. Immunol."},{"key":"1309_CR27","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","volume":"25","author":"J Yuan","year":"2024","unstructured":"Yuan, J. & Ofengeim, D. A guide to cell death pathways. Nat. Rev. Mol. Cell Biol. 25, 379\u2013395 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1309_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1189\/jlb.0306164","volume":"81","author":"ME Bianchi","year":"2006","unstructured":"Bianchi, M. E. DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81, 1\u20135 (2006).","journal-title":"J. Leukoc. Biol."},{"key":"1309_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1169560","volume":"14","author":"G Koncz","year":"2023","unstructured":"Koncz, G. et al. Damage-mediated macrophage polarization in sterile inflammation. Front. Immunol. 14, 1169560 (2023).","journal-title":"Front. Immunol."},{"key":"1309_CR30","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41577-024-01027-3","volume":"24","author":"Y Huang","year":"2024","unstructured":"Huang, Y., Jiang, W. & Zhou, R. DAMP sensing and sterile inflammation: intracellular, intercellular and inter-organ pathways. Nat. Rev. Immunol. 24, 703\u2013719 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"1309_CR31","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/s41577-024-01102-9","volume":"24","author":"G Kroemer","year":"2024","unstructured":"Kroemer, G., Mont\u00e9gut, L., Kepp, O. & Zitvogel, L. The danger theory of immunity revisited. Nat. Rev. Immunol. 24, 912\u2013928 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"1309_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.915099","volume":"12","author":"XX Zhu","year":"2022","unstructured":"Zhu, X. X. et al. The novel role of metabolism-associated molecular patterns in sepsis. Front. Cell. Infect. Microbiol. 12, 915099 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1309_CR33","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/0014-4827(61)90192-6","volume":"25","author":"L Hayflick","year":"1961","unstructured":"Hayflick, L. & Moorhead, P. S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25, 585\u2013621 (1961).","journal-title":"Exp. Cell Res."},{"key":"1309_CR34","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1371\/journal.pbio.0060301","volume":"6","author":"JP Copp\u00e9","year":"2008","unstructured":"Copp\u00e9, J. P. et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6, 2853\u20132868 (2008).","journal-title":"PLoS Biol."},{"key":"1309_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000599","volume":"18","author":"N Basisty","year":"2020","unstructured":"Basisty, N. et al. A proteomic atlas of senescence-associated secretomes for aging biomarker development. PLoS Biol. 18, e3000599 (2020).","journal-title":"PLoS Biol."},{"key":"1309_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/acel.70120","volume":"24","author":"C Hoong","year":"2025","unstructured":"Hoong, C. et al. Biomarkers of cellular senescence in type 2 diabetes mellitus. Aging Cell 24, e70120 (2025).","journal-title":"Aging Cell"},{"key":"1309_CR37","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1159\/000281826","volume":"191","author":"A Stolzing","year":"2010","unstructured":"Stolzing, A., Sellers, D., Llewelyn, O. & Scutt, A. Diabetes induced changes in rat mesenchymal stem cells. Cell Tissues Organs 191, 453\u2013465 (2010).","journal-title":"Cell Tissues Organs"},{"key":"1309_CR38","doi-asserted-by":"publisher","first-page":"13915","DOI":"10.1073\/pnas.94.25.13915","volume":"94","author":"C Cerami","year":"1997","unstructured":"Cerami, C. et al. Tobacco smoke is a source of toxic reactive glycation products. Proc. Natl Acad. Sci. USA 94, 13915\u201313920 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1309_CR39","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1007\/s00125-004-1451-2","volume":"47","author":"R Meerwaldt","year":"2004","unstructured":"Meerwaldt, R. et al. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 47, 1324\u20131330 (2004).","journal-title":"Diabetologia"},{"key":"1309_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179330","volume":"12","author":"RP van Waateringe","year":"2017","unstructured":"van Waateringe, R. P. et al. The association between various smoking behaviors, cotinine biomarkers and skin autofluorescence, a marker for advanced glycation end product accumulation. PLoS ONE 12, e0179330 (2017).","journal-title":"PLoS ONE"},{"key":"1309_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/1541-4337.70130","volume":"24","author":"S Wang","year":"2025","unstructured":"Wang, S. et al. Emerging technologies in reducing dietary advanced glycation end products in ultra-processed foods: formation, health risks, and innovative mitigation strategies. Compr. Rev. Food Sci. Food Saf. 24, e70130 (2025).","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"key":"1309_CR42","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.3390\/cells12131684","volume":"12","author":"M Portero-Otin","year":"2023","unstructured":"Portero-Otin, M., de la Maza, M. P. & Uribarri, J. Dietary advanced glycation end products: their role in the insulin resistance of aging. Cells 12, 1684 (2023).","journal-title":"Cells"},{"key":"1309_CR43","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s12276-021-00561-7","volume":"53","author":"W Rungratanawanich","year":"2021","unstructured":"Rungratanawanich, W., Qu, Y., Wang, X., Essa, M. M. & Song, B. J. Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury. Exp. Mol. Med. 53, 168\u2013188 (2021).","journal-title":"Exp. Mol. Med."},{"key":"1309_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2021.117754","volume":"288","author":"BAM Bandowe","year":"2021","unstructured":"Bandowe, B. A. M. et al. The chemical composition and toxicological effects of fine particulate matter (PM(2.5)) emitted from different cooking styles. Environ. Pollut. 288, 117754 (2021).","journal-title":"Environ. Pollut."},{"key":"1309_CR45","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00441-014-1905-x","volume":"358","author":"DB Barton","year":"2014","unstructured":"Barton, D. B. et al. Primary alveolar macrophages exposed to diesel particulate matter increase RAGE expression and activate RAGE signaling. Cell Tissue Res. 358, 229\u2013238 (2014).","journal-title":"Cell Tissue Res."},{"key":"1309_CR46","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1289\/ehp.1002520","volume":"119","author":"PR Reynolds","year":"2011","unstructured":"Reynolds, P. R., Wasley, K. M. & Allison, C. H. Diesel particulate matter induces receptor for advanced glycation end-products (RAGE) expression in pulmonary epithelial cells, and RAGE signaling influences NF-\u03baB-mediated inflammation. Environ. Health Perspect. 119, 332\u2013336 (2011).","journal-title":"Environ. Health Perspect."},{"key":"1309_CR47","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/j.1432-1033.1995.0408h.x","volume":"230","author":"N Araki","year":"1995","unstructured":"Araki, N. et al. Macrophage scavenger receptor mediates the endocytic uptake and degradation of advanced glycation end products of the Maillard reaction. Eur. J. Biochem. 230, 408\u2013415 (1995).","journal-title":"Eur. J. Biochem."},{"key":"1309_CR48","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/386292a0","volume":"386","author":"H Suzuki","year":"1997","unstructured":"Suzuki, H. et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386, 292\u2013296 (1997).","journal-title":"Nature"},{"key":"1309_CR49","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S1056-8727(01)00208-2","volume":"16","author":"N Ohgami","year":"2002","unstructured":"Ohgami, N. et al. CD36, serves as a receptor for advanced glycation endproducts (AGE). J. Diabetes Complicat. 16, 56\u201359 (2002).","journal-title":"J. Diabetes Complicat."},{"key":"1309_CR50","doi-asserted-by":"publisher","first-page":"12613","DOI":"10.1074\/jbc.M210211200","volume":"278","author":"Y Tamura","year":"2003","unstructured":"Tamura, Y. et al. FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products. J. Biol. Chem. 278, 12613\u201312617 (2003).","journal-title":"J. Biol. Chem."},{"key":"1309_CR51","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S0014-5793(01)03325-7","volume":"511","author":"T Jono","year":"2002","unstructured":"Jono, T. et al. Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) serves as an endothelial receptor for advanced glycation end products (AGE). FEBS Lett. 511, 170\u2013174 (2002).","journal-title":"FEBS Lett."},{"key":"1309_CR52","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/BF03401604","volume":"1","author":"H Vlassara","year":"1995","unstructured":"Vlassara, H. et al. Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex. Mol. Med. 1, 634\u2013646 (1995).","journal-title":"Mol. Med."},{"key":"1309_CR53","doi-asserted-by":"publisher","first-page":"11047","DOI":"10.1073\/pnas.93.20.11047","volume":"93","author":"YM Li","year":"1996","unstructured":"Li, Y. M. et al. Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. Proc. Natl Acad. Sci. USA 93, 11047\u201311052 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1309_CR54","doi-asserted-by":"publisher","first-page":"14987","DOI":"10.1016\/S0021-9258(18)42137-0","volume":"267","author":"AM Schmidt","year":"1992","unstructured":"Schmidt, A. M. et al. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J. Biol. Chem. 267, 14987\u201314997 (1992).","journal-title":"J. Biol. Chem."},{"key":"1309_CR55","doi-asserted-by":"publisher","first-page":"14998","DOI":"10.1016\/S0021-9258(18)42138-2","volume":"267","author":"M Neeper","year":"1992","unstructured":"Neeper, M. et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267, 14998\u201315004 (1992).","journal-title":"J. Biol. Chem."},{"key":"1309_CR56","first-page":"1699","volume":"143","author":"J Brett","year":"1993","unstructured":"Brett, J. et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am. J. Pathol. 143, 1699\u20131712 (1993).","journal-title":"Am. J. Pathol."},{"key":"1309_CR57","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1096\/fj.08-109033","volume":"22","author":"A Raucci","year":"2008","unstructured":"Raucci, A. et al. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J. 22, 3716\u20133727 (2008).","journal-title":"FASEB J."},{"key":"1309_CR58","first-page":"L516","volume":"300","author":"N Yamakawa","year":"2011","unstructured":"Yamakawa, N., Uchida, T., Matthay, M. A. & Makita, K. Proteolytic release of the receptor for advanced glycation end products from in vitro and in situ alveolar epithelial cells. Am. J. Physiol. 300, L516\u2013L525 (2011).","journal-title":"Am. J. Physiol."},{"key":"1309_CR59","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1042\/bj20021371","volume":"370","author":"H Yonekura","year":"2003","unstructured":"Yonekura, H. et al. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem. J. 370, 1097\u20131109 (2003).","journal-title":"Biochem. J."},{"key":"1309_CR60","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s12291-022-01081-5","volume":"38","author":"M Salehi","year":"2023","unstructured":"Salehi, M., Amiri, S., Ilghari, D., Hasham, L. F. A. & Piri, H. The remarkable roles of the receptor for advanced glycation end products (RAGE) and its soluble isoforms in COVID-19: the importance of RAGE pathway in the lung injuries. Indian J. Clin. Biochem. 38, 159\u2013171 (2023).","journal-title":"Indian J. Clin. Biochem."},{"key":"1309_CR61","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12931-021-01686-z","volume":"22","author":"KA Pratte","year":"2021","unstructured":"Pratte, K. A. et al. Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD. Respir. Res. 22, 127 (2021).","journal-title":"Respir. Res."},{"key":"1309_CR62","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.3390\/ijms23073439","volume":"23","author":"M Steenbeke","year":"2022","unstructured":"Steenbeke, M. et al. The role of advanced glycation end products and its soluble receptor in kidney diseases. Int. J. Mol. Sci. 23, 3439 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1309_CR63","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/bs.acc.2023.08.005","volume":"117","author":"C Delrue","year":"2023","unstructured":"Delrue, C., Delanghe, J. R. & Speeckaert, M. M. The role of sRAGE in cardiovascular diseases. Adv. Clin. Chem. 117, 53\u2013102 (2023).","journal-title":"Adv. Clin. Chem."},{"key":"1309_CR64","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0092-8674(00)80801-6","volume":"97","author":"MA Hofmann","year":"1999","unstructured":"Hofmann, M. A. et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100\/calgranulin polypeptides. Cell 97, 889\u2013901 (1999).","journal-title":"Cell"},{"key":"1309_CR65","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/35012626","volume":"405","author":"A Taguchi","year":"2000","unstructured":"Taguchi, A. et al. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405, 354\u2013360 (2000).","journal-title":"Nature"},{"key":"1309_CR66","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1189\/jlb.0306170","volume":"81","author":"D Foell","year":"2007","unstructured":"Foell, D., Wittkowski, H., Vogl, T. & Roth, J. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J. Leukoc. Biol. 81, 28\u201337 (2007).","journal-title":"J. Leukoc. Biol."},{"key":"1309_CR67","doi-asserted-by":"publisher","first-page":"7370","DOI":"10.1074\/jbc.M306793200","volume":"279","author":"JS Park","year":"2004","unstructured":"Park, J. S. et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279, 7370\u20137377 (2004).","journal-title":"J. Biol. Chem."},{"key":"1309_CR68","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3390\/biom14040412","volume":"14","author":"A Rojas","year":"2024","unstructured":"Rojas, A., Lindner, C., Schneider, I., Gonzalez, I. & Uribarri, J. The RAGE axis: a relevant inflammatory hub in human diseases. Biomolecules 14, 412 (2024).","journal-title":"Biomolecules"},{"key":"1309_CR69","doi-asserted-by":"publisher","first-page":"9889","DOI":"10.1016\/S0021-9258(17)36966-1","volume":"269","author":"SD Yan","year":"1994","unstructured":"Yan, S. D. et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors\/binding proteins. J. Biol. Chem. 269, 9889\u20139897 (1994).","journal-title":"J. Biol. Chem."},{"key":"1309_CR70","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1161\/CIRCRESAHA.107.165308","volume":"102","author":"JS Chang","year":"2008","unstructured":"Chang, J. S. et al. Oxygen deprivation triggers upregulation of early growth response-1 by the receptor for advanced glycation end products. Circ. Res. 102, 905\u2013913 (2008).","journal-title":"Circ. Res."},{"key":"1309_CR71","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.137289","volume":"5","author":"L Senatus","year":"2020","unstructured":"Senatus, L. et al. RAGE impairs murine diabetic atherosclerosis regression and implicates IRF7 in macrophage inflammation and cholesterol metabolism. JCI Insight 5, e137289 (2020).","journal-title":"JCI Insight"},{"key":"1309_CR72","first-page":"411","volume":"24","author":"S Jaisson","year":"2021","unstructured":"Jaisson, S. & Gillery, P. Methods to assess advanced glycation end-products. Curr. Opin. Clin. Nutr. Metab. Care 24, 411\u2013415 (2021).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"1309_CR73","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00062-024-01493-1","volume":"35","author":"CM Mooshage","year":"2025","unstructured":"Mooshage, C. M. et al. Intradermal advanced glycation end-products relate to reduced sciatic nerve structural integrity in type 2 diabetes. Clin. Neuroradiol. 35, 385\u2013394 (2025).","journal-title":"Clin. Neuroradiol."},{"key":"1309_CR74","volume":"46","author":"J Barreto","year":"2024","unstructured":"Barreto, J. et al. Skin accumulation of advanced glycation end-products predicts kidney outcomes in type 2 diabetes: results from the Brazilian Diabetes Study. J. Bras. Nefrol. 46, e20240047 (2024).","journal-title":"J. Bras. Nefrol."},{"key":"1309_CR75","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.numecd.2021.10.007","volume":"32","author":"Q Jin","year":"2022","unstructured":"Jin, Q. et al. Skin autofluorescence is associated with progression of kidney disease in type 2 diabetes: a prospective cohort study from the Hong Kong diabetes biobank. Nutr. Metab. Cardiovasc. Dis. 32, 436\u2013446 (2022).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"1309_CR76","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3390\/biomedicines12040890","volume":"12","author":"D Reurean-Pintilei","year":"2024","unstructured":"Reurean-Pintilei, D. et al. Associations between skin autofluorescence levels with cardiovascular risk and diabetes complications in patients with type 2 diabetes. Biomedicines 12, 890 (2024).","journal-title":"Biomedicines"},{"key":"1309_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2024.101524","volume":"50","author":"F Alkhami","year":"2024","unstructured":"Alkhami, F. et al. Skin autofluorescence of advanced glycation end-products relates to new cardiovascular events in type 2 diabetes: a longitudinal observational study. Diabetes Metab. 50, 101524 (2024).","journal-title":"Diabetes Metab."},{"key":"1309_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2023.108595","volume":"37","author":"G Borderie","year":"2023","unstructured":"Borderie, G. et al. The skin autofluorescence of advanced glycation end-products relates to the development of foot ulcers in type 2 diabetes: a longitudinal observational study. J. Diabetes Complicat. 37, 108595 (2023).","journal-title":"J. Diabetes Complicat."},{"key":"1309_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.696156","volume":"8","author":"L Ying","year":"2021","unstructured":"Ying, L. et al. Association of advanced glycation end products with lower-extremity atherosclerotic disease in type 2 diabetes mellitus. Front. Cardiovasc. Med. 8, 696156 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"1309_CR80","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3721","volume":"40","author":"I Mart\u00ednez-Garc\u00eda","year":"2024","unstructured":"Mart\u00ednez-Garc\u00eda, I. et al. Non-invasive skin autofluorescence as a screening method for diabetic retinopathy. Diabetes Metab. Res. Rev. 40, e3721 (2024).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"1309_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2022.108356","volume":"36","author":"S Papachristou","year":"2022","unstructured":"Papachristou, S. et al. Skin advanced glycation end products as a screening tool of neuropathy in type 2 diabetes mellitus. J. Diabetes Complicat. 36, 108356 (2022).","journal-title":"J. Diabetes Complicat."},{"key":"1309_CR82","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/1753-0407.13309","volume":"14","author":"H Liu","year":"2022","unstructured":"Liu, H. et al. Association of skin autofluorescence with low bone density\/osteoporosis and osteoporotic fractures in type 2 diabetes mellitus. J. Diabetes 14, 571\u2013585 (2022).","journal-title":"J. Diabetes"},{"key":"1309_CR83","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1111\/jdi.70169","volume":"16","author":"M Takeshita","year":"2025","unstructured":"Takeshita, M. et al. Fingertip skin autofluorescence as a non-invasive marker for vascular complications in patients with type 2 diabetes. J. Diabetes Investig. 16, 2201\u20132212 (2025).","journal-title":"J. Diabetes Investig."},{"key":"1309_CR84","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1172\/JCI116552","volume":"92","author":"PJ Beisswenger","year":"1993","unstructured":"Beisswenger, P. J., Moore, L. L., Brinck-Johnsen, T. & Curphey, T. J. Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy. J. Clin. Invest. 92, 212\u2013217 (1993).","journal-title":"J. Clin. Invest."},{"key":"1309_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-69822-5","volume":"14","author":"S Kato","year":"2024","unstructured":"Kato, S., Matsumura, T., Sugawa, H. & Nagai, R. Correlation between serum advanced glycation end-products and vascular complications in patient with type 2 diabetes. Sci. Rep. 14, 18722 (2024).","journal-title":"Sci. Rep."},{"key":"1309_CR86","first-page":"1649","volume":"143","author":"Y Nakamura","year":"1993","unstructured":"Nakamura, Y. et al. Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus. Am. J. Pathol. 143, 1649\u20131656 (1993).","journal-title":"Am. J. Pathol."},{"key":"1309_CR87","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1161\/01.CIR.0000086014.80477.0D","volume":"108","author":"F Cipollone","year":"2003","unstructured":"Cipollone, F. et al. The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control. Circulation 108, 1070\u20131077 (2003).","journal-title":"Circulation"},{"key":"1309_CR88","doi-asserted-by":"publisher","first-page":"138760","DOI":"10.1016\/j.ijbiomac.2024.138760","volume":"288","author":"YN Wang","year":"2025","unstructured":"Wang, Y. N. & Liu, S. The role of ALDHs in lipid peroxidation-related diseases. Int. J. Biol. Macromol. 288, 138760 (2025).","journal-title":"Int. J. Biol. Macromol."},{"key":"1309_CR89","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/2012","volume":"4","author":"L Park","year":"1998","unstructured":"Park, L. et al. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat. Med. 4, 1025\u20131031 (1998).","journal-title":"Nat. Med."},{"key":"1309_CR90","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.2337\/db07-1808","volume":"57","author":"A Soro-Paavonen","year":"2008","unstructured":"Soro-Paavonen, A. et al. Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes. Diabetes 57, 2461\u20132469 (2008).","journal-title":"Diabetes"},{"key":"1309_CR91","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/cvr\/cvp036","volume":"82","author":"L Sun","year":"2009","unstructured":"Sun, L. et al. RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice. Cardiovasc. Res. 82, 371\u2013381 (2009).","journal-title":"Cardiovasc. Res."},{"key":"1309_CR92","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1172\/JCI32703","volume":"118","author":"E Harja","year":"2008","unstructured":"Harja, E. et al. Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE\u2212\/\u2212 mice. J. Clin. Invest. 118, 183\u2013194 (2008).","journal-title":"J. Clin. Invest."},{"key":"1309_CR93","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1681\/ASN.V1191656","volume":"11","author":"N Tanji","year":"2000","unstructured":"Tanji, N. et al. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease. J. Am. Soc. Nephrol. 11, 1656\u20131666 (2000).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1309_CR94","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1172\/JCI11771","volume":"108","author":"Y Yamamoto","year":"2001","unstructured":"Yamamoto, Y. et al. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J. Clin. Invest. 108, 261\u2013268 (2001).","journal-title":"J. Clin. Invest."},{"key":"1309_CR95","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/S0002-9440(10)63909-0","volume":"162","author":"TM Wendt","year":"2003","unstructured":"Wendt, T. M. et al. RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am. J. Pathol. 162, 1123\u20131137 (2003).","journal-title":"Am. J. Pathol."},{"key":"1309_CR96","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.2337\/db06-0221","volume":"55","author":"KM Myint","year":"2006","unstructured":"Myint, K. M. et al. RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin. Diabetes 55, 2510\u20132522 (2006).","journal-title":"Diabetes"},{"key":"1309_CR97","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.2337\/db09-1766","volume":"59","author":"N Reiniger","year":"2010","unstructured":"Reiniger, N. et al. Deletion of the receptor for advanced glycation end products reduces glomerulosclerosis and preserves renal function in the diabetic OVE26 mouse. Diabetes 59, 2043\u20132054 (2010).","journal-title":"Diabetes"},{"key":"1309_CR98","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2337\/diabetes.53.1.166","volume":"53","author":"A Flyvbjerg","year":"2004","unstructured":"Flyvbjerg, A. et al. Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice. Diabetes 53, 166\u2013172 (2004).","journal-title":"Diabetes"},{"key":"1309_CR99","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1677\/joe.1.06524","volume":"188","author":"LJ Jensen","year":"2006","unstructured":"Jensen, L. J. et al. Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice. J. Endocrinol. 188, 493\u2013501 (2006).","journal-title":"J. Endocrinol."},{"key":"1309_CR100","doi-asserted-by":"publisher","DOI":"10.1177\/1479164121990533","volume":"18","author":"A Sotokawauchi","year":"2021","unstructured":"Sotokawauchi, A. et al. DNA aptamer raised against receptor for advanced glycation end products suppresses renal tubular damage and improves insulin resistance in diabetic mice. Diabetes Vasc. Dis. Res. 18, 1479164121990533 (2021).","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"1309_CR101","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/s00125-014-3291-z","volume":"57","author":"G Tesch","year":"2014","unstructured":"Tesch, G. et al. Deletion of bone-marrow-derived receptor for AGEs (RAGE) improves renal function in an experimental mouse model of diabetes. Diabetologia 57, 1977\u20131985 (2014).","journal-title":"Diabetologia"},{"key":"1309_CR102","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/MED.0b013e328350a6e1","volume":"19","author":"KF Moseley","year":"2012","unstructured":"Moseley, K. F. Type 2 diabetes and bone fractures. Curr. Opin. Endocrinol. Diabetes Obes. 19, 128\u2013135 (2012).","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"1309_CR103","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S2213-8587(15)00283-1","volume":"4","author":"VV Shanbhogue","year":"2016","unstructured":"Shanbhogue, V. V., Mitchell, D. M., Rosen, C. J. & Bouxsein, M. L. Type 2 diabetes and the skeleton: new insights into sweet bones. Lancet Diabetes Endocrinol. 4, 159\u2013173 (2016).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1309_CR104","doi-asserted-by":"publisher","first-page":"100132","DOI":"10.1016\/j.mbm.2025.100132","volume":"3","author":"T Hung","year":"2025","unstructured":"Hung, T., Broz, K. S., Walk, R. E. & Tang, S. Y. The sex-specific effects of RAGE signaling and type 2 diabetes on mouse cortical bone mechanics, structure, and material properties. Mechanobiol. Med. 3, 100132 (2025).","journal-title":"Mechanobiol. Med."},{"key":"1309_CR105","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.3390\/ijms23094579","volume":"23","author":"R Ramasamy","year":"2022","unstructured":"Ramasamy, R., Shekhtman, A. & Schmidt, A. M. The RAGE\/DIAPH1 signaling axis & implications for the pathogenesis of diabetic complications. Int. J. Mol. Sci. 23, 4579 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1309_CR106","doi-asserted-by":"publisher","first-page":"1128872","DOI":"10.3389\/fphar.2023.1128872","volume":"14","author":"K Taguchi","year":"2023","unstructured":"Taguchi, K. & Fukami, K. RAGE signaling regulates the progression of diabetic complications. Front. Pharmacol. 14, 1128872 (2023).","journal-title":"Front. Pharmacol."},{"key":"1309_CR107","doi-asserted-by":"publisher","DOI":"10.1186\/s12938-023-01194-9","volume":"22","author":"Z Lu","year":"2023","unstructured":"Lu, Z., Fan, B., Li, Y. & Zhang, Y. RAGE plays key role in diabetic retinopathy: a review. Biomed. Eng. Online 22, 128 (2023).","journal-title":"Biomed. Eng. Online"},{"key":"1309_CR108","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1055\/s-0034-1367023","volume":"122","author":"A Hidmark","year":"2014","unstructured":"Hidmark, A. et al. A new paradigm to understand and treat diabetic neuropathy. Exp. Clin. Endocrinol. Diabetes 122, 201\u2013207 (2014).","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"1309_CR109","doi-asserted-by":"publisher","first-page":"7213","DOI":"10.1021\/acs.jmedchem.7b00058","volume":"60","author":"S Bongarzone","year":"2017","unstructured":"Bongarzone, S., Savickas, V., Luzi, F. & Gee, A. D. Targeting the receptor for advanced glycation endproducts (RAGE): a medicinal chemistry perspective. J. Med. Chem. 60, 7213\u20137232 (2017).","journal-title":"J. Med. Chem."},{"key":"1309_CR110","doi-asserted-by":"publisher","first-page":"6957","DOI":"10.1021\/bi7003735","volume":"46","author":"BM Dattilo","year":"2007","unstructured":"Dattilo, B. M. et al. The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units. Biochemistry 46, 6957\u20136970 (2007).","journal-title":"Biochemistry"},{"key":"1309_CR111","doi-asserted-by":"publisher","first-page":"34457","DOI":"10.1074\/jbc.M801465200","volume":"283","author":"BI Hudson","year":"2008","unstructured":"Hudson, B. I. et al. Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42. J. Biol. Chem. 283, 34457\u201334468 (2008).","journal-title":"J. Biol. Chem."},{"key":"1309_CR112","doi-asserted-by":"publisher","first-page":"5133","DOI":"10.1074\/jbc.M111.277731","volume":"287","author":"V Rai","year":"2012","unstructured":"Rai, V. et al. Signal transduction in receptor for advanced glycation end products (RAGE): solution structure of C-terminal rage (ctRAGE) and its binding to mDia1. J. Biol. Chem. 287, 5133\u20135144 (2012).","journal-title":"J. Biol. Chem."},{"key":"1309_CR113","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.str.2016.06.021","volume":"24","author":"J Xue","year":"2016","unstructured":"Xue, J. et al. Change in the molecular dimension of a RAGE-ligand complex triggers RAGE signaling. Structure 24, 1509\u20131522 (2016).","journal-title":"Structure"},{"key":"1309_CR114","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1161\/CIRCRESAHA.111.262519","volume":"110","author":"F Tour\u00e9","year":"2012","unstructured":"Tour\u00e9, F. et al. Formin mDia1 mediates vascular remodeling via integration of oxidative and signal transduction pathways. Circ. Res. 110, 1279\u20131293 (2012).","journal-title":"Circ. Res."},{"key":"1309_CR115","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ebiom.2017.11.012","volume":"26","author":"KM O\u2019Shea","year":"2017","unstructured":"O\u2019Shea, K. M. et al. The formin, DIAPH1, is a key modulator of myocardial ischemia\/reperfusion injury. eBioMedicine 26, 165\u2013174 (2017).","journal-title":"eBioMedicine"},{"key":"1309_CR116","first-page":"F1601","volume":"315","author":"MB Manigrasso","year":"2018","unstructured":"Manigrasso, M. B., Friedman, R. A., Ramasamy, R., D\u2019Agati, V. & Schmidt, A. M. Deletion of the formin Diaph1 protects from structural and functional abnormalities in the murine diabetic kidney. Am. J. Physiol 315, F1601\u2013F1612 (2018).","journal-title":"Am. J. Physiol"},{"key":"1309_CR117","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s42003-023-04643-2","volume":"6","author":"L Senatus","year":"2023","unstructured":"Senatus, L. et al. DIAPH1 mediates progression of atherosclerosis and regulates hepatic lipid metabolism in mice. Commun. Biol. 6, 280 (2023).","journal-title":"Commun. Biol."},{"key":"1309_CR118","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1093\/cvr\/cvaa206","volume":"117","author":"I Abe","year":"2021","unstructured":"Abe, I. et al. Disruption of actin dynamics regulated by Rho effector mDia1 attenuates pressure overload-induced cardiac hypertrophic responses and exacerbates dysfunction. Cardiovasc. Res. 117, 1103\u20131117 (2021).","journal-title":"Cardiovasc. Res."},{"key":"1309_CR119","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.5275","volume":"38","author":"RG Menon","year":"2025","unstructured":"Menon, R. G. et al. Assessment of cardiac and skeletal muscle metabolites using (1)H-MRS and chemical-shift encoded magnetic resonance imaging: impact of diabetes, RAGE, and DIAPH1. NMR Biomed. 38, e5275 (2025).","journal-title":"NMR Biomed."},{"key":"1309_CR120","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42521-x","volume":"14","author":"G Yepuri","year":"2023","unstructured":"Yepuri, G. et al. DIAPH1-MFN2 interaction regulates mitochondria-SR\/ER contact and modulates ischemic\/hypoxic stress. Nat. Commun. 14, 6900 (2023).","journal-title":"Nat. Commun."},{"key":"1309_CR121","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.1073\/pnas.1108220109","volume":"109","author":"D Sebasti\u00e1n","year":"2012","unstructured":"Sebasti\u00e1n, D. et al. Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis. Proc. Natl Acad. Sci. USA 109, 5523\u20135528 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1309_CR122","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/bs.mcb.2015.10.003","volume":"132","author":"G V\u00e1zquez-Victorio","year":"2016","unstructured":"V\u00e1zquez-Victorio, G., Gonz\u00e1lez-Espinosa, C., Espinosa-Riquer, Z. P. & Mac\u00edas-Silva, M. GPCRs and actin-cytoskeleton dynamics. Methods Cell Biol. 132, 165\u2013188 (2016).","journal-title":"Methods Cell Biol."},{"key":"1309_CR123","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.1038\/sj.emboj.7600879","volume":"24","author":"M Lammers","year":"2005","unstructured":"Lammers, M., Rose, R., Scrima, A. & Wittinghofer, A. The regulation of mDia1 by autoinhibition and its release by Rho*GTP. EMBO J. 24, 4176\u20134187 (2005).","journal-title":"EMBO J."},{"key":"1309_CR124","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.chembiol.2025.09.004","volume":"32","author":"GG Theophall","year":"2025","unstructured":"Theophall, G. G. et al. RAGE-mediated activation of the formin DIAPH1 and human macrophage inflammation are inhibited by a small molecule antagonist. Cell Chem. Biol. 32, 1221\u20131234 (2025).","journal-title":"Cell Chem. Biol."},{"key":"1309_CR125","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/bs.apcsb.2024.09.014","volume":"143","author":"D Vladimirova","year":"2025","unstructured":"Vladimirova, D., Staneva, S. & Ugrinova, I. Multifaceted role of HMGB1: from nuclear functions to cytoplasmic and extracellular signaling in inflammation and cancer-review. Adv. Protein Chem. Struct. Biol. 143, 271\u2013300 (2025).","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"1309_CR126","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10930-024-10186-0","volume":"43","author":"S Paramasivam","year":"2024","unstructured":"Paramasivam, S., Perumal, S. S. & Ekambaram, S. P. Computational deciphering of the role of S100A8 and S100A9 proteins and their changes in the structure assembly influences their interaction with TLR4, RAGE, and CD36. Protein J. 43, 243\u2013258 (2024).","journal-title":"Protein J."},{"key":"1309_CR127","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0006-2952(00)00287-2","volume":"60","author":"PJ Thornalley","year":"2000","unstructured":"Thornalley, P. J., Yurek-George, A. & Argirov, O. K. Kinetics and mechanism of the reaction of aminoguanidine with the alpha-oxoaldehydes glyoxal, methylglyoxal, and 3-deoxyglucosone under physiological conditions. Biochem. Pharmacol. 60, 55\u201365 (2000).","journal-title":"Biochem. Pharmacol."},{"key":"1309_CR128","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000075627","volume":"24","author":"WK Bolton","year":"2004","unstructured":"Bolton, W. K. et al. Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy. Am. J. Nephrol. 24, 32\u201340 (2004).","journal-title":"Am. J. Nephrol."},{"key":"1309_CR129","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1196\/annals.1333.093","volume":"1043","author":"PA Voziyan","year":"2005","unstructured":"Voziyan, P. A. & Hudson, B. G. Pyridoxamine: the many virtues of a Maillard reaction inhibitor. Ann. N. Y. Acad. Sci. 1043, 807\u2013816 (2005).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"1309_CR130","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1210\/clinem\/dgae700","volume":"110","author":"AV Brossfield","year":"2025","unstructured":"Brossfield, A. V. et al. The effects of the AGE inhibitor pyridoxamine on bone in older women with type 2 diabetes: a randomized clinical trial. J. Clin. Endocrinol. Metab. 110, 961\u2013972 (2025).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1309_CR131","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1681\/ASN.2011030272","volume":"23","author":"EJ Lewis","year":"2012","unstructured":"Lewis, E. J. et al. Pyridorin in type 2 diabetic nephropathy. J. Am. Soc. Nephrol. 23, 131\u2013136 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1309_CR132","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1517\/13543784.10.11.1977","volume":"10","author":"S Vasan","year":"2001","unstructured":"Vasan, S., Foiles, P. G. & Founds, H. W. Therapeutic potential of AGE inhibitors and breakers of AGE protein cross-links. Expert. Opin. Investig. Drugs 10, 1977\u20131987 (2001).","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"1309_CR133","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/eurjhf\/hfp207","volume":"12","author":"S Willemsen","year":"2010","unstructured":"Willemsen, S. et al. Effects of alagebrium, an advanced glycation end-product breaker, in patients with chronic heart failure: study design and baseline characteristics of the BENEFICIAL trial. Eur. J. Heart Fail. 12, 294\u2013300 (2010).","journal-title":"Eur. J. Heart Fail."},{"key":"1309_CR134","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/HJH.0b013e328013e7dd","volume":"25","author":"SJ Zieman","year":"2007","unstructured":"Zieman, S. J. et al. Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension. J. Hypertens. 25, 577\u2013583 (2007).","journal-title":"J. Hypertens."},{"key":"1309_CR135","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1073\/pnas.040558497","volume":"97","author":"M Asif","year":"2000","unstructured":"Asif, M. et al. An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness. Proc. Natl Acad. Sci. USA 97, 2809\u20132813 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1309_CR136","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00726-010-0783-0","volume":"42","author":"N Rabbani","year":"2012","unstructured":"Rabbani, N. & Thornalley, P. J. Methylglyoxal, glyoxalase 1 and the dicarbonyl proteome. Amino Acids 42, 1133\u20131142 (2012).","journal-title":"Amino Acids"},{"key":"1309_CR137","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.3390\/ijms23052453","volume":"23","author":"N Rabbani","year":"2022","unstructured":"Rabbani, N. & Thornalley, P. J. Emerging glycation-based therapeutics-glyoxalase 1 inducers and glyoxalase 1 inhibitors. Int. J. Mol. Sci. 23, 2453 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1309_CR138","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.2337\/db18-0933","volume":"68","author":"H Li","year":"2019","unstructured":"Li, H. et al. Ameliorating methylglyoxal-induced progenitor cell dysfunction for tissue repair in diabetes. Diabetes 68, 1287\u20131302 (2019).","journal-title":"Diabetes"},{"key":"1309_CR139","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/0006-291X(69)90445-8","volume":"35","author":"R Vince","year":"1969","unstructured":"Vince, R. & Wadd, W. B. Glyoxalase inhibitors as potential anticancer agents. Biochem. Biophys. Res. Commun. 35, 593\u2013598 (1969).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1309_CR140","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.3390\/antiox11112131","volume":"11","author":"A Scir\u00e8","year":"2022","unstructured":"Scir\u00e8, A. et al. Glyoxalase 2: towards a broader view of the second player of the glyoxalase system. Antioxidants 11, 2131 (2022).","journal-title":"Antioxidants"},{"key":"1309_CR141","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.pharmthera.2017.02.030","volume":"177","author":"K Byun","year":"2017","unstructured":"Byun, K. et al. Advanced glycation end-products produced systemically and by macrophages: a common contributor to inflammation and degenerative diseases. Pharmacol. Ther. 177, 44\u201355 (2017).","journal-title":"Pharmacol. Ther."},{"key":"1309_CR142","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/382685a0","volume":"382","author":"SD Yan","year":"1996","unstructured":"Yan, S. D. et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer\u2019s disease. Nature 382, 685\u2013691 (1996).","journal-title":"Nature"},{"key":"1309_CR143","doi-asserted-by":"publisher","first-page":"149","DOI":"10.14283\/jpad.2018.18","volume":"5","author":"AH Burstein","year":"2018","unstructured":"Burstein, A. H. et al. Development of azeliragon, an oral small molecule antagonist of the receptor for advanced glycation endproducts, for the potential slowing of loss of cognition in mild Alzheimer\u2019s disease. J. Prev. Alzheimers Dis. 5, 149\u2013154 (2018).","journal-title":"J. Prev. Alzheimers Dis."},{"key":"1309_CR144","unstructured":"Genetic Engineering & Biotechnology News. vTv halts trials of Alzheimer\u2019s candidate azeliragon after phase III failure https:\/\/www.genengnews.com\/news\/vtv-halts-trials-of-alzheimers-candidate-azeliragon-after-phase-iii-failure\/ (2018)."},{"key":"1309_CR145","doi-asserted-by":"publisher","DOI":"10.1002\/alz.041198","volume":"16","author":"AH Burstein","year":"2020","unstructured":"Burstein, A. H., Dunn, I., Gooch, A. M. & Valcarce, C. Effects of azeliragon on ADAS-cog and CDR domains and individual items in patients with mild Alzheimer\u2019s disease and type 2 diabetes (T2D). Alzheimer\u2019s Dement. 16, e041198 (2020).","journal-title":"Alzheimer\u2019s Dement."},{"key":"1309_CR146","doi-asserted-by":"publisher","DOI":"10.1038\/srep22450","volume":"6","author":"MB Manigrasso","year":"2016","unstructured":"Manigrasso, M. B. et al. Small molecule inhibition of ligand-stimulated RAGE-DIAPH1 signal transduction. Sci. Rep. 6, 22450 (2016).","journal-title":"Sci. Rep."},{"key":"1309_CR147","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf7084","volume":"13","author":"MB Manigrasso","year":"2021","unstructured":"Manigrasso, M. B. et al. Small-molecule antagonism of the interaction of the RAGE cytoplasmic domain with DIAPH1 reduces diabetic complications in mice. Sci. Transl. Med. 13, eabf7084 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1309_CR148","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adp4986","volume":"17","author":"C Li","year":"2025","unstructured":"Li, C. et al. AGER-dependent macropinocytosis drives resistance to KRAS-G12D-targeted therapy in advanced pancreatic cancer. Sci. Transl. Med. 17, eadp4986 (2025).","journal-title":"Sci. Transl. Med."},{"key":"1309_CR149","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1091\/mbc.e12-08-0597","volume":"24","author":"D Li","year":"2013","unstructured":"Li, D., Dammer, E. B., Lucki, N. C. & Sewer, M. B. cAMP-stimulated phosphorylation of diaphanous 1 regulates protein stability and interaction with binding partners in adrenocortical cells. Mol. Biol. Cell 24, 848\u2013857 (2013).","journal-title":"Mol. Biol. Cell"},{"key":"1309_CR150","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08957-w","volume":"10","author":"K Nishimura","year":"2019","unstructured":"Nishimura, K. et al. Cdk1-mediated DIAPH1 phosphorylation maintains metaphase cortical tension and inactivates the spindle assembly checkpoint at anaphase. Nat. Commun. 10, 981 (2019).","journal-title":"Nat. Commun."},{"key":"1309_CR151","doi-asserted-by":"publisher","first-page":"325","DOI":"10.4315\/0362-028X-46.4.325","volume":"46","author":"JM Jay","year":"1983","unstructured":"Jay, J. M., Rivers, G. M. & Boisvert, W. E. Antimicrobial properties of \u03b1-dicarbonyl and related compounds. J. Food Prot. 46, 325\u2013329 (1983).","journal-title":"J. Food Prot."},{"key":"1309_CR152","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130533","volume":"10","author":"JG Kiselar","year":"2015","unstructured":"Kiselar, J. G. et al. Modification of \u03b2-defensin-2 by dicarbonyls methylglyoxal and glyoxal inhibits antibacterial and chemotactic function in vitro. PLoS ONE 10, e0130533 (2015).","journal-title":"PLoS ONE"},{"key":"1309_CR153","doi-asserted-by":"publisher","first-page":"125905","DOI":"10.1016\/j.foodchem.2019.125905","volume":"311","author":"S Brighina","year":"2020","unstructured":"Brighina, S., Restuccia, C., Arena, E., Palmeri, R. & Fallico, B. Antibacterial activity of 1,2-dicarbonyl compounds and the influence of the in vitro assay system. Food Chem. 311, 125905 (2020).","journal-title":"Food Chem."},{"key":"1309_CR154","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1161\/ATVBAHA.113.302281","volume":"34","author":"KH Gaens","year":"2014","unstructured":"Gaens, K. H. et al. N\u03b5-(carboxymethyl)lysine-receptor for advanced glycation end product axis is a key modulator of obesity-induced dysregulation of adipokine expression and insulin resistance. Arterioscler. Thromb. Vasc. Biol. 34, 1199\u20131208 (2014).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1309_CR155","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.2337\/db13-1636","volume":"63","author":"F Song","year":"2014","unstructured":"Song, F. et al. RAGE regulates the metabolic and inflammatory response to high-fat feeding in mice. Diabetes 63, 1948\u20131965 (2014).","journal-title":"Diabetes"},{"key":"1309_CR156","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.celrep.2019.06.061","volume":"28","author":"C Hurtado Del Pozo","year":"2019","unstructured":"Hurtado Del Pozo, C. et al. A receptor of the immunoglobulin superfamily regulates adaptive thermogenesis. Cell Rep. 28, 773\u2013791 (2019).","journal-title":"Cell Rep."},{"key":"1309_CR157","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1002\/oby.23774","volume":"31","author":"RA Wilson","year":"2023","unstructured":"Wilson, R. A. et al. Pharmacological antagonism of receptor for advanced glycation end products signaling promotes thermogenesis, healthful body mass and composition, and metabolism in mice. Obesity 31, 1825\u20131843 (2023).","journal-title":"Obesity"},{"key":"1309_CR158","doi-asserted-by":"publisher","DOI":"10.1093\/cdn\/nzac046","volume":"6","author":"CJ Popp","year":"2022","unstructured":"Popp, C. J. et al. Soluble receptor for advanced glycation end products (sRAGE) isoforms predict changes in resting energy expenditure in adults with obesity during weight loss. Curr. Dev. Nutr. 6, nzac046 (2022).","journal-title":"Curr. Dev. Nutr."},{"key":"1309_CR159","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-019-0514-7","volume":"18","author":"C Ba\u00f1uls","year":"2019","unstructured":"Ba\u00f1uls, C. et al. Malnutrition impairs mitochondrial function and leukocyte activation. Nutr. J. 18, 89 (2019).","journal-title":"Nutr. J."},{"key":"1309_CR160","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fnins.2019.00059","volume":"13","author":"IAK Nilsson","year":"2019","unstructured":"Nilsson, I. A. K. The anx\/anx mouse \u2013 a valuable resource in anorexia nervosa research. Front. Neurosci. 13, 59 (2019).","journal-title":"Front. Neurosci."},{"key":"1309_CR161","first-page":"153","volume":"139","author":"AE Morales","year":"2004","unstructured":"Morales, A. E., P\u00e9rez-Jim\u00e9nez, A., Hidalgo, M. C., Abell\u00e1n, E. & Cardenete, G. Oxidative stress and antioxidant defenses after prolonged starvation in Dentex dentex liver. Comp. Biochem. Physiol. C 139, 153\u2013161 (2004).","journal-title":"Comp. Biochem. Physiol. C"},{"key":"1309_CR162","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1210\/jc.2015-2750","volume":"100","author":"N Wang","year":"2015","unstructured":"Wang, N. et al. Is exposure to famine in childhood and economic development in adulthood associated with diabetes? J. Clin. Endocrinol. Metab. 100, 4514\u20134523 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1309_CR163","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s00125-016-4148-4","volume":"60","author":"N Wang","year":"2017","unstructured":"Wang, N. et al. Exposure to severe famine in the prenatal or postnatal period and the development of diabetes in adulthood: an observational study. Diabetologia 60, 262\u2013269 (2017).","journal-title":"Diabetologia"},{"key":"1309_CR164","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086903","volume":"9","author":"L Sessa","year":"2014","unstructured":"Sessa, L. et al. The receptor for advanced glycation end-products (RAGE) is only present in mammals, and belongs to a family of cell adhesion molecules (CAMs). PLoS ONE 9, e86903 (2014).","journal-title":"PLoS ONE"},{"key":"1309_CR165","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s42003-025-08222-5","volume":"8","author":"GG Theophall","year":"2025","unstructured":"Theophall, G. G. et al. Negative cooperativity regulates ligand activation of DIAPH1 and other diaphanous related formins. Commun. Biol. 8, 776 (2025).","journal-title":"Commun. Biol."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-026-01309-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-026-01309-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-026-01309-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:02:22Z","timestamp":1791392542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-026-01309-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":165,"alternative-id":["1309"],"URL":"https:\/\/doi.org\/10.1038\/s41574-026-01309-x","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"assertion":[{"value":"16 September 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.M.S., R.R. and A.S. are named as inventors on patent applications owned by New York University that cover the work detailed in this manuscript.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}